Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Dia-Präsentation von Merck Gesellschaft mbH.
Micardis(R) - Micardis Plus(R) - Klinische Wirksamkeit (39 Abbildungen)
Übersicht


Zum ersten Bild Abb. 16: Telmisartan - Ramipril Abb. 17: Telmisartan - Ramipril Abb. 18: Morgendlicher Blutdruckanstieg Aktuelles Bild - Abb. 19: Telmisartan - Perindopril Abb. 20: Telmisartan - Perindopril Abb. 21: Telmisartan - Enalapril Abb. 22: Telmisartan - Amlodipin Zum letzten Bild
Abbildung 19: Telmisartan - Perindopril
Telmisartan 80 mg reduced mean DBP in the last 8 h of the dosing interval compared with perindopril 4 mg (P≤0.05).1 This study was a 6-week, double-blind, ABPM trial in 60 patients with mild-to-moderate hypertension. DBP control (24-h mean DBP <85 mmHg) was observed in 66.6% of telmisartan-treated patients but only 46.6% of perindopril-treated patients (P<0.05). 1. Nalbantgil I, et al. The efficacy of telmisartan compared with perindopril in patients with mild-to-moderate hypertension. Int J Clin Pract 2004; 58: 50–54.
 
Telmisartan - Perindopril
Vorheriges Bild Nächstes Bild   


Abbildung 19: Telmisartan - Perindopril
Telmisartan 80 mg reduced mean DBP in the last 8 h of the dosing interval compared with perindopril 4 mg (P≤0.05).1 This study was a 6-week, double-blind, ABPM trial in 60 patients with mild-to-moderate hypertension. DBP control (24-h mean DBP <85 mmHg) was observed in 66.6% of telmisartan-treated patients but only 46.6% of perindopril-treated patients (P<0.05). 1. Nalbantgil I, et al. The efficacy of telmisartan compared with perindopril in patients with mild-to-moderate hypertension. Int J Clin Pract 2004; 58: 50–54.
 
copyright © 2003–2017 Krause & Pachernegg GmbH | Sitemap | Impressum
 
Werbung